According to a new study, the number of mutations in healthy vs leukemic blood stem cells does not differ. Instead, the location of mutations in the DNA is relevant. Furthermore, the authors developed a method for tracing the lineage of cancer cells. The findings were published recently in Cell Reports.

Subscribe to eNewsletters
Get the latest industry news and technology updates
related to your research interests.

Researchers from the Princes Máxima Center for Pediatric Oncology were looking to understand the effect of mutation buildups on leukemia development. Because mutations in blood stem cells are the cause of leukemia, they hypothesized that people with leukemia would have more mutations than healthy people.

Graphic Abstract

They studied this by using whole genome sequencing to analyze healthy blood stem cells from individuals of different ages. Stem cells divide about once every 40 weeks and an average of eleven mutations were found to occur during each division. The older the test subjects, the more mutations had accumulated, but these mutations did not appear to be detrimental.  Contrary to their original belief, healthy individuals accumulated just as many mutations as those with acute myeloid leukemia (AML).

The researchers also described their method for tracing the development of hematopoiesis using mutation patterns of HSPCs. They were able to determine which cell a cancer cell derived from using this method. This information could someday help in developing more effective treatment strategies for cancer patients.

Image: Lifelong mutation accumulation in human hematopoietic stem and progenitor cells, which is explained by three distinct mutational signatures. Shared somatic mutations between cells of the same donor enable the construction of a developmental lineage tree and quantification of each branch to mature blood cell populations. Image courtesy of: Osorio et al., Cell Reports, 2018.